Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Thiazolidinedione analogues for the treatment of metabolic diseases

Thiazolidinedione analogues for the treatment of metabolic diseases

US Patent 8304441 · Granted Nov 6, 2012

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Therapeutic compounds and compositions2024
Thiazolidinedione analogs for the treatment of NAFLD and metabolic diseases2024
Therapeutic compounds and compositions2021
Antiproliferative pyrimidine-based compounds2020
Automatically identifying synonyms within a token-based database management syst2020
Tricyclic lactams for use in HSPC-sparing treatments for Rb-positive abnormal ce2019
Therapeutic compounds and compositions2019
Reducing comparisons for token-based entity resolution2019
Therapeutic compounds and compositions2018
Tricyclic lactams for use in HSPC-sparing treatments for RB-positive abnormal ce2017
Therapeutic compounds and compositions2016
Modified creatine compounds2016